metricas
covid
Journal of Healthcare Quality Research Costos de la administración intravenosa vs. subcutánea del trastuzumab en paci...
Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINAL
Costos de la administración intravenosa vs. subcutánea del trastuzumab en pacientes peruanas con cáncer de mama HER2 positivo. Un análisis observacional de los costos directos e indirectos
Costs of intravenous vs. subcutaneous administration of trastuzumab in peruvian patients with HER2-positive breast cancer – An observational analysis of direct and indirect costs
Henry Olivera Changraa, José Fernando Robles Díaza,b,
Corresponding author
bayern014@hotmail.com

Autor para correspondencia.
a Instituto Regional de Enfermedades Neoplásicas del Centro, Concepción, Junín, Perú
b Universidad Peruana Los Andes, Huancayo, Junín, Perú
Read
5358
Times
was read the article
362
Total PDF
4996
Total HTML
Share statistics
Article information
ISSN: 26036479
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 51 5 56
2025 11 357 42 399
2025 10 341 30 371
2025 9 301 43 344
2025 8 277 21 298
2025 7 313 19 332
2025 6 366 8 374
2025 5 258 21 279
2025 4 267 14 281
2025 3 336 11 347
2025 2 340 11 351
2025 1 267 5 272
2024 12 275 7 282
2024 11 289 10 299
2024 10 208 18 226
2024 9 246 39 285
2024 8 181 8 189
2024 7 123 14 137
2024 6 137 9 146
2024 5 48 20 68
2023 8 2 0 2
2023 6 2 0 2
2023 4 2 2 4
2023 3 1 0 1
2022 10 1 0 1
2022 9 1 0 1
2022 7 1 0 1
2022 6 4 3 7
2022 5 1 0 1
2022 4 0 2 2
Show all

Follow this link to access the full text of the article